175 related articles for article (PubMed ID: 8601366)
1. Different protective effects of tauroursodeoxycholate, ursodeoxycholate, and 23-methyl-ursodeoxycholate against taurolithocholate-induced cholestasis.
Baumgartner U; Schölmerich J; Sellinger M; Reinhardt M; Ruf G; Farthmann EH
Dig Dis Sci; 1996 Feb; 41(2):250-5. PubMed ID: 8601366
[TBL] [Abstract][Full Text] [Related]
2. Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats.
Tsukahara K; Kanai S; Ohta M; Kitani K
Liver; 1993 Oct; 13(5):262-9. PubMed ID: 8259039
[TBL] [Abstract][Full Text] [Related]
3. Taurohyocholate, taurocholate, and tauroursodeoxycholate but not tauroursocholate and taurodehydrocholate counteract effects of taurolithocholate in rat liver.
Schölmerich J; Kitamura S; Baumgartner U; Miyai K; Gerok W
Res Exp Med (Berl); 1990; 190(2):121-9. PubMed ID: 2349395
[TBL] [Abstract][Full Text] [Related]
4. Influence of oral treatment with ursodeoxycholic and tauroursodeoxycholic acids on estrogen-induced cholestasis in rats: effects on bile formation and liver plasma membranes.
Bouchard G; Yousef IM; Tuchweber B
Liver; 1993 Aug; 13(4):193-202. PubMed ID: 8377596
[TBL] [Abstract][Full Text] [Related]
5. Diminution of an acute cyclosporin-induced cholestasis by tauroursodeoxycholate in the rat.
Queneau PE; Bertault-Perès P; Mesdjian E; Durand A; Montet JC
Transplantation; 1993 Sep; 56(3):530-4. PubMed ID: 8212145
[TBL] [Abstract][Full Text] [Related]
6. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U
Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
[TBL] [Abstract][Full Text] [Related]
7. Tauroursodeoxycholate prevents taurolithocholate-induced cholestasis and toxicity in rat liver.
Schölmerich J; Baumgartner U; Miyai K; Gerok W
J Hepatol; 1990 May; 10(3):280-3. PubMed ID: 2365980
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis.
Sánchez Pozzi EJ; Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Rodríguez Garay EA; Mottino AD
J Pharmacol Exp Ther; 2003 Jul; 306(1):279-86. PubMed ID: 12663690
[TBL] [Abstract][Full Text] [Related]
9. Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents.
Yoon YB; Hagey LR; Hofmann AF; Gurantz D; Michelotti EL; Steinbach JH
Gastroenterology; 1986 Apr; 90(4):837-52. PubMed ID: 3949115
[TBL] [Abstract][Full Text] [Related]
10. Difference in the effects of ursodeoxycholate and its taurine conjugate on the biliary excretion of sulfobromophthalein in the rat.
Kanai S; Kitani K; Sato Y
J Hepatol; 1990 Mar; 10(2):174-9. PubMed ID: 2332588
[TBL] [Abstract][Full Text] [Related]
11. Effect of tauroursodeoxycholate on actin filament alteration induced by cholestatic agents. A study in isolated rat hepatocyte couplets.
Thibault N; Maurice M; Maratrat M; Cordier A; Feldmann G; Ballet F
J Hepatol; 1993 Nov; 19(3):367-76. PubMed ID: 8151096
[TBL] [Abstract][Full Text] [Related]
12. Estradiol-17 beta-glucuronide-induced cholestasis. Effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate.
Sano N; Takikawa H; Yamanaka M
J Hepatol; 1993 Feb; 17(2):241-6. PubMed ID: 8445238
[TBL] [Abstract][Full Text] [Related]
13. Hepatoprotection with tauroursodeoxycholate and beta muricholate against taurolithocholate induced cholestasis: involvement of signal transduction pathways.
Milkiewicz P; Roma MG; Elias E; Coleman R
Gut; 2002 Jul; 51(1):113-9. PubMed ID: 12077103
[TBL] [Abstract][Full Text] [Related]
14. Reduced cholestatic potency of taurolithocholate during backward perfusion of the rat liver.
Baumgartner U; Hardison WG; Miyai K
Lab Invest; 1987 Jun; 56(6):576-82. PubMed ID: 3599905
[TBL] [Abstract][Full Text] [Related]
15. Prevention of Mrp2 activity impairment in ethinylestradiol-induced cholestasis by ursodeoxycholate in the rat.
Crocenzi FA; D'Andrea V; Catania VA; Luquita MG; Pellegrino JM; Ochoa JE; Mottino AD; Sánchez Pozzi EJ
Drug Metab Dispos; 2005 Jul; 33(7):888-91. PubMed ID: 15843489
[TBL] [Abstract][Full Text] [Related]
16. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.
Heuman DM; Mills AS; McCall J; Hylemon PB; Pandak WM; Vlahcevic ZR
Gastroenterology; 1991 Jan; 100(1):203-11. PubMed ID: 1983822
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts.
Heuman DM; Bajaj R
Gastroenterology; 1994 May; 106(5):1333-41. PubMed ID: 8174892
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholate alleviates alcoholic fatty liver damage in rats.
Oliva L; Beaugé F; Choquart D; Montet AM; Guitaoui M; Montet JC
Alcohol Clin Exp Res; 1998 Oct; 22(7):1538-43. PubMed ID: 9802540
[TBL] [Abstract][Full Text] [Related]
19. Influence of backward perfusion on ursodeoxycholate-induced choleresis in isolated in situ rat liver.
Perez Barriocanal F; Marin JJ; Dumont M; Erlinger S
J Hepatol; 1990 Sep; 11(2):165-71. PubMed ID: 2254627
[TBL] [Abstract][Full Text] [Related]
20. Tauroursodeoxycholate and S-adenosyl-L-methionine exert an additive ameliorating effect on taurolithocholate-induced cholestasis: a study in isolated rat hepatocyte couplets.
Milkiewicz P; Mills CO; Roma MG; Ahmed-Choudhury J; Elias E; Coleman R
Hepatology; 1999 Feb; 29(2):471-6. PubMed ID: 9918924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
